KIR2.4 Inhibitors
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Baicalein | 491-67-8 | sc-200494 sc-200494A sc-200494B sc-200494C | 10 mg 100 mg 500 mg 1 g | $32.00 $42.00 $162.00 $292.00 | 12 | |
Affects KIR2.4 indirectly by inhibiting the NF-κB pathway. Baicalein interferes with the phosphorylation and degradation of IκBα, reducing NF-κB activation. This modulation of the NF-κB pathway can influence the transcription of genes involved in KIR2.4 expression and function. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Indirectly modulates KIR2.4 by inhibiting p38 MAPK signaling. SB-203580 disrupts the phosphorylation of p38 MAPK, affecting downstream signaling pathways that influence the expression and function of KIR2.4. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor influencing KIR2.4 indirectly. LY294002 disrupts the PI3K/AKT pathway, altering downstream signaling cascades that impact KIR2.4 expression and function. The modulation of this pathway can influence the cellular processes related to KIR2.4 regulation. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Affects KIR2.4 indirectly through Src family kinase inhibition. Dasatinib disrupts downstream signaling, altering pathways involved in KIR2.4 expression and function. The modulation of these pathways can impact cellular processes related to KIR2.4 regulation. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Modulates KIR2.4 indirectly by inhibiting the MAPK/ERK pathway. PD98059 disrupts the phosphorylation of MEK1/2, affecting downstream signaling cascades that influence KIR2.4 expression and function. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Influences KIR2.4 indirectly through PI3K inhibition. Wortmannin disrupts the PI3K/AKT pathway, altering downstream signaling cascades that impact KIR2.4 expression and function. The modulation of this pathway can influence cellular processes related to KIR2.4 regulation. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Indirectly modulates KIR2.4 by inhibiting the JNK pathway. SP600125 disrupts JNK signaling, affecting downstream pathways that influence KIR2.4 expression and function. The modulation of these pathways can impact cellular processes related to KIR2.4 regulation. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
Indirectly influences KIR2.4 by inhibiting the MAPK/ERK pathway. U0126 disrupts the phosphorylation of MEK1/2, affecting downstream signaling cascades that influence KIR2.4 expression and function. | ||||||
AG-490 | 133550-30-8 | sc-202046C sc-202046A sc-202046B sc-202046 | 5 mg 50 mg 25 mg 10 mg | $84.00 $329.00 $223.00 $87.00 | 35 | |
JAK2 inhibitor indirectly affecting KIR2.4. AG490 disrupts the JAK2/STAT pathway, altering downstream signaling cascades that influence KIR2.4 expression and function. The modulation of this pathway can influence cellular processes related to KIR2.4 regulation. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
Modulates KIR2.4 indirectly by inhibiting NF-κB signaling. BAY 11-7082 interferes with the phosphorylation and degradation of IκBα, reducing NF-κB activation. This modulation of the NF-κB pathway can influence the transcription of genes involved in KIR2.4 expression and function. | ||||||